Microsoft and Bristol Myers Squibb join forces to advance AI lung cancer detection, aiming to improve early diagnosis and ...

Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. | Microsoft ...

Bristol Myers Squibb (NYSE: BMY, "BMS"), a global leader in oncology, today announced an agreement with Microsoft, a market leader in AI-powered radiology and clinical workflow technologies, aiming to ...

Bristol Myers Squibb (BMY) stock is in focus as the company partners with Microsoft (MSFT) for the early detection of lung ...

Find out how machine learning identifies country-specific health system drivers shaping global cancer survival and highlights ...